IRONWOOD PHARMACEUTICALS, INC. (IRWD)

Import this data to Google Sheets with:

=jivedata("IRWD","financials")

Full statements spill as a table. For one cell: =jivedata("IRWD","Revenue") or =jivedata("IRWD","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

IRONWOOD PHARMACEUTICALS, INC.

IRWD • CIK 0001446847

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$442,735	$351,410	$296,151	$389,316
Operating Income (Loss)	$-945,430	$93,124	$98,502	$234,169
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-948,069	$65,198	$70,025	$207,378
Income Tax Expense (Benefit)	$83,490	$64,318	$46,008	$77,510
Net Income (Loss) Attributable to Parent	$-1,002,239	$880	$24,017	$129,868
Weighted Average Number of Shares Outstanding, Basic	155,435,000	159,083,000	161,842,000	164,422,000
Weighted Average Number of Shares Outstanding, Diluted	155,435,000	160,084,000	162,983,000	168,669,000
Research and Development Expense	$116,085	$111,421	$95,136	$88,692
Selling, General and Administrative Expense	$158,314	$144,272	$82,256	$64,547
Costs and Expenses	$1,388,165	$258,286	$197,649	$155,147
InterestExpenseNonoperating	—	$33,034	$32,746	$32,664
Investment Income, Net	$18,971	$4,468	$4,076	$5,672
Other Nonoperating Income (Expense)	—	$640	$193	$201
Nonoperating Income (Expense)	$-2,639	$-27,926	$-28,477	$-26,791

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$92,154	$88,559	$215,456	$79,127
Accounts Receivable, after Allowance for Credit Loss, Current	$129,122	$81,886	$46,745	$112,732
Property, Plant and Equipment, Net	$5,585	$4,495	$3,408	$2,913
Prepaid Expense and Other Assets, Current	$12,012	$11,923	$11,977	$7,342
Operating Lease, Right-of-Use Asset	$12,586	$11,028	$9,340	$8,443
Assets, Current	$233,288	$182,368	$274,178	$199,201
Finite-Lived Intangible Assets, Net	$3,682	$2,860	$2,040	$1,633
Deferred Income Tax Assets, Net	$212,324	$144,234	$103,433	$69,064
Other Assets, Noncurrent	$3,608	$5,923	$4,502	$3,874
Assets	$471,073	$350,908	$396,901	$285,128
Convertible Debt, Noncurrent	$198,309	$198,988	$198,988	$199,160
Operating Lease, Liability, Noncurrent	$14,543	$12,304	$9,870	$8,581
Long-term Line of Credit, Noncurrent	$300,000	$385,000	$385,000	$385,000
Other Liabilities, Noncurrent	$28,415	$17,105	$21,648	$20,536
Accounts Payable, Current	$7,830	$2,127	$2,898	$911
Operating Lease, Liability, Current	$3,126	$3,189	$3,252	$3,285
Convertible Debt, Current	$199,560	$199,560	$199,680	$199,855
Liabilities, Current	$276,101	$38,846	$242,218	$32,854
Common Stock, Value, Issued	$156	$160	$163	$165
Additional Paid in Capital, Common Stock	$1,355,195	$1,395,317	$1,412,780	$1,419,970
Retained Earnings (Accumulated Deficit)	$-1,698,615	$-1,697,735	$-1,673,718	$-1,581,654
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-3,031	$923	$-1,060	$-324
Stockholders' Equity Attributable to Parent	$-346,295	$-301,335	$-261,835	$-161,843
Preferred Stock, Shares Authorized	75,000,000	75,000,000	75,000,000	75,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	500,000,000	500,000,000	500,000,000	500,000,000
Common Stock, Shares, Issued	156,354,238	160,205,899	163,058,316	165,239,947

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-1,031,559	$880	$24,017	$129,868
Net Cash Provided by (Used in) Operating Activities	$183,427	$103,549	$127,044	$185,555
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$-53	$-32	$-329	$296
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-565,784	$-3,595	$126,897	$-13,725
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$92,154	$88,559	$215,456	$327,446
Depreciation	$1,575	$2,011	$1,881	$1,835
Payments to Acquire Property, Plant, and Equipment	$273	$142	$34	$34
Gain (Loss) on Disposition of Property Plant Equipment	$-2	$-75	$-89	$-89
Net Cash Provided by (Used in) Investing Activities	$-1,026,318	$-142	$-34	$-34
Share-based Payment Arrangement, Noncash Expense	$32,005	$29,850	$17,250	$14,324
Paid-in-Kind Interest	—	—	$1,668	$1,644
Operating Lease, Right-of-Use Asset, Amortization Expense	—	—	$1,688	$1,758
Deferred Income Taxes and Tax Credits	$72,637	$68,090	$40,801	$60,395
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	$6,357	$11,013	$216	$425
Payment, Tax Withholding, Share-based Payment Arrangement	—	$737	$737	$737
Repayments of Convertible Debt	$120,699	$200,000	$200,000	—
Proceeds from Long-term Lines of Credit	$400,000	$150,000	$150,000	$150,000
Payments of Debt Issuance Costs	$2,886	$2,246	$2,246	$2,246
Repayments of Long-term Lines of Credit	$100,000	$65,000	$65,000	$65,000
Net Cash Provided by (Used in) Financing Activities	$277,160	$-106,970	$216	$-199,575
Interest Paid, Excluding Capitalized Interest, Operating Activities	$13,552	$32,563	$30,333	$30,333
Income Taxes Paid, Net	$9,945	$8,408	$3,543	$3,543
Increase (Decrease) in Accounts Receivable	$-924	$-47,236	$-35,148	$26,557
Increase (Decrease) in Prepaid Expense and Other Assets	$-4,220	$-89	$-367	$-5,419
Increase (Decrease) in Other Operating Assets	$319	$854	$-447	$-301
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$12,380	$-20,208	$6,201	$875
IncreaseDecreaseInOperatingLeaseLiability	$-1,995	$-2,176	$-2,371	$-2,471
Increase (Decrease) in Other Current Liabilities	$507	$-10,256	$3,964	$-420

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("IRWD","financials")

Full statements spill as a table. For one cell: =jivedata("IRWD","Revenue") or =jivedata("IRWD","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.